Game Changers in Type 2 Diabetes: After Three Antihypertensives, What’s Next? – MM1407
Hypertension is an important risk factor for both micro- and macrovascular complications in people with type 2 diabetes and can be difficult to control.
Modern Medicine – July 2014
Pioglitazone Reverses Insulin Resistance in Type 2 Diabetes – MM1311
Insulin resistance is a common feature and contains several cardiovascular risk factors: dyslipidaemia, hypertension, glucose intolerance, hypercoagulability,
obesity, hyperinsulinaemia and low-grade inflammation.
Modern Medicine – November/December 2013
Game Changers in Type 2 Diabetes: Microalbuminuria – MM1310
The diabetes complication of microalbuminuria indicates considerable renal damage and an increased risk of cardiovascular events. Its treatment involves improving all aspects of diabetes management and targeting the microalbuminuria itself.
Modern Medicine – October 2013
Urinary Tract Infections in Women with Diabetes – MM1309
Diabetes and female sex are among the risk factors for urinary tract infections. The presence of such infections should be sought in women with diabetes, to preserve renal function and avoid the glycaemic, fluid and electrolyte disturbances associated with systemic unwellness.
Modern Medicine – September 2013
Glycaemic Control and Weight Loss in Type 2 Diabetes – MM1308
Globally it was estimated in 2010 that there were 285m people living with type 2 diabetes, making up approximately 90% of diabetic cases. Traditionally considered a disease of adults, type 2 diabetes is increasingly diagnosed in children due to rising obesity rates. Type 2 diabetes is diagnosed as frequently as type 1 diabetes in teenagers in the US. It is recognised as a global epidemic by the World Health Organization.
Modern Medicine – August 2013
The Practical Value of the Metabolic Syndrome – MM1308
The presence of the metabolic syndrome can be a useful tool to help practitioners identify patients at higher risk for cardiovascular disease and type 2 diabetes. To help reduce such risks, patients with the metabolic syndrome should be targeted with interventions following a multifaceted approach.
Modern Medicine – August 2013
Transient Neurological Troubles in Patients with Type 2 Diabetes – MM1305
Transient neurological attacks, early warning signs of cerebrovascular disease, are usually differentiated by their history. As type 2 diabetes is an important risk factor for a transient ischaemic attack (TIA) and subsequent stroke,
this article focuses on the acute, usually urgent management of this focal transient neurological problem and its prevention.
Modern Medicine – May 2013
Common Myths and Misunderstandings in Type 1 Diabetes – MM1304
Although some of the abundant myths in circulation about type 1 diabetes may have been useful in the past, many are misleading now and may lead to inappropriate management. This article discusses some of the more prevalent ones that may mislead doctors.
Modern Medicine – April 2013
Diabetes-Related Foot Problems – Urgent Management of Ulcers – MM1303
Diabetes-related foot problems are largely preventable with appropriate medical assessment, patient education and on-going monitoring. However, many patients with diabetes present with foot ulcers that require emergency attention, as in the case described here.
Modern Medicine – March 2013
Game changers in Type 2 Diabetes – The Implications of Panretinal Laser Therapy – MM1302
Panretinal laser therapy, an effective treatment for sight-threatening
diabetic retinopathy, should prompt a major review of diabetes management
because retinopathy suggests that other microvascular disease
is present, and probably macrovascular disease too.
Modern Medicine – February 2013
